logo-loader
RNS
viewConvaTec Group PLC

Director/PDMR Shareholding

/**/ ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: #954F72 } .at{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.at{}p.w,li.w,div.w{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}span.cc{font-size:10.5pt;font-family:"Arial","sans-serif"}p.ce{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; text-align: center}span.cb{font-size: 10.5pt;font-family:"Arial","sans-serif"}p.cf{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:11.55pt;margin-right:0cm;margin-bottom: 11.55pt;margin-left:0cm;text-align:justify;text-justify:inter-ideograph; line-height:normal}p.cg{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:11.55pt;margin-right:0cm;margin-bottom: 11.55pt;margin-left:0cm;line-height:normal}span.by{font-size:10.5pt; font-family:"Arial","sans-serif"}p.ch{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align: center} table.ci{margin-left:-7.35pt;border:solid windowtext 1.0pt}td.bt{width:475.1pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.cj{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold}span.bv{font-size:10.5pt;line-height:107%; font-family:"Arial","sans-serif"}td.bq{width:21.3pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.ck{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 8.5pt}span.bs{font-size:10.5pt; line-height:107%;font-family:"Arial","sans-serif"}td.bo{width:453.8pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.cl{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 9.05pt}td.bm{width:128.8pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm} p.cm{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 8.85pt}td.bk{width:325.0pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.cn{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-indent:6.35pt}p.co{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 11.55pt; margin-left: 0cm; margin-right: 0cm; margin-top: 11.55pt; text-align: right}td.bh{width:127.55pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.cp{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 11.55pt; margin-left: 0cm; margin-right: 0cm; margin-top: 11.55pt}td.bg{width:326.25pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}table.cq{border-collapse:collapse;border:none}td.be{width:89.3pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.cr{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal} td.bd{width:67.2pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.bc{width:89.3pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}td.bb{width:67.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.cs{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 11.55pt; margin-left: 0cm; margin-right: 0cm; margin-top: 11.55pt}td.ay{border:none}p.ct{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify;text-justify:inter-ideograph}span.aw{font-size:10.5pt;font-family: "Arial","sans-serif"}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}span.au{font-size:10.5pt;line-height:107%;font-family: "Arial","sans-serif"} /**/
RNS Number : 8217P
ConvaTec Group PLC
14 October 2019
 

14 October 2019

ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 9 October 2019 Karim Bitar, Chief Executive Officer and a PDMR, sold 215,235 Shares at £1.76 per share to cover the remaining balance of income tax liabilities due on the vesting and exercise of a share award made to him under the Company's 2019 Long Term Incentive Plan ("LTIP") on 30 September 2019.

Mr Bitar's resulting shareholding is 989,830 Shares, being the balance from vesting and exercise of the 2019 LTIP award of 1,869,647 Shares (incorrectly stated as 1,869,646 Share in the announcement dated 4 October 2019) less a total of 879,817 Shares sold which was equivalent to the income tax liability with respect to such awards (sold in two tranches on 30 September and 9 October respectively).

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, provides details of the number of Shares sold on 9 October 2019.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

2019 LTIP

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

CEO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

Financial instrument, type of instrument

Identification code

 

Ordinary shares of 10p each

 GB0002074580

b)

Nature of the transaction

Sale of shares arising from the exercise of the 2019 LTIP, which vested on 30 September 2019, to offset income tax and social security liabilities due on the exercise.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.757

215,235

 

d)

Aggregated information

Aggregated volume

Price

 

Average Price(s)

Volume(s)

£1.757

215,235

 

e)

Date of the transaction

2019-10-09

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

       

Enquiries

Media

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                      +44 (0)7500 141 435

Mark Reynolds, Director Investor Relations, ConvaTec           +44 (0)7551 036 625

[email protected]

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFISIVLSLIA

Quick facts: ConvaTec Group PLC

Price: 189

Market: LSE
Market Cap: £3.75 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE